AstraZeneca to buy drug developer CinCor Pharma AstraZeneca has said it has struck a deal to buy US-based drug developer CinCor Pharma for up to $1.8 billion to increase its stock of heart and kidney drugs. Business • 09 Jan 23
AstraZeneca to buy drug developer CinCor Pharma AstraZeneca has said it has struck a deal to buy US-based drug developer CinCor Pharma for up to $1.8 billion to increase its stock of heart and kidney drugs. Business • 09 Jan 23
